After receiving the Corona virus vaccine , Members of the American Centers for Disease Control and Prevention Advisory Committee made it clear on Monday that Americans need to prepare for the possibility of feeling slightly unwell .
The Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention met to discuss whether it should recommend the use of any vaccine against “Covid-19” that may be authorized by the US Food and Drug Administration.
Volunteers who participate in vaccine trials reported that they often feel influenza-like effects after receiving a dose of the vaccine, and members of the Immunization Practices Advisory Committee, as well as contact representatives who participate in the discussion, indicated that this may affect people’s desire to get the vaccine in the first place. First, or get the second dose from a two-dose regimen.
During the meeting, Dr. Sandra Fryhofer of Emory University School of Medicine in Georgia, USA, which represents the American Medical Association, said, “As a practicing physician, I must make sure that patients return to get the second dose,” stressing the need to educate patients about getting the vaccine .It wouldn’t look like a “walk in the park”.
The goal of getting the vaccine is to induce an immune response in the body, and this can sometimes cause flu-like symptoms such as body aches, or even fever and headache.
Patricia Stinschfield, of Children’s Hospitals and Clinics in Minnesota, which represents the American National Association of Pediatric Practitioners, said that providers should be willing to explain this to people who receive vaccine.
“These are immune responses, so if you feel something after getting a shot of the vaccine, you should expect to feel it,” Stinschfield said during the meeting. And when you do, it is normal to have some arm pain or some fatigue, or some pain in the body, or Even some fever. “
Stinschfield added that some people may feel tired after getting vaccinated, to the point where they have to stay home for a day.
For his part, Dr. Paul Hunter, of the Health Department in Milwaukee, Wisconsin, and a voting member of the committee, said that it would be important to describe the first vaccine recipients for their experience and share it with others.
Hunter stressed that “the people who can get the vaccine at the earliest time will benefit everyone,” adding: “I think we will need to honor them because they will tell us how they feel.”
“I think these people are likely to be health care workers and are more likely to be prepared for this kind of task,” Hunter added.
And Dr. Sarah Oliver of the Centers for Disease Control and Prevention indicated during the meeting, which lasted for 5 hours, that general preparedness to obtain a vaccine for Coronavirus has been declining since the spring season, but it may improve when people begin to hear more information about the safety and effectiveness of various vaccines.
Oliver explained that the CDC was looking at various surveys about people’s attitudes towards the vaccine, noting that between 40% and 80% of those surveyed said they would like to get the vaccine.
Oliver added that many adults have confirmed their intentions to receive the “Covid-19” vaccine; however concerns have been raised about side effects, unknown efficacy, and the speed of the licensing process.
Oliver pointed out that acceptance of the vaccine was the highest among the Asian American group and the lowest among the African American group.
This result is worrying for the Advisory Committee on Immunization Practices, which wants to ensure that any approved vaccine reaches the groups most affected by the pandemic, and dark-skinned people are among the most affected by “Covid-19”.
One survey showed that while nursing staff agreed that vaccines were likely to be safe and effective, only 34% of nursing staff would want to volunteer to get the vaccine, which is also a matter of concern, according to Oliver.
Members of the Advisory Committee believe that these concerns can be addressed through educational campaigns and the dissemination of data on promising vaccine trials.
For example, the Pfizer and Moderna vaccines have shown to be 95% effective in preventing asymptomatic disease with no major safety concerns.
Any plan to distribute the Coronavirus vaccine must take into account fair and equitable access for all, especially groups that are disproportionately affected by the Covid-19 pandemic.
In a document published at the beginning of the meeting, members of the Advisory Committee on Immunization Practices emphasized that equitable access to the vaccine is at the top of the list of priorities.
The Centers for Disease Control, the National Academies of Sciences, Engineering, and Medicine, as well as other advisors, have each suggested four groups that should get the vaccine at the forefront – that is, health care workers, other essential workers, adults with high-risk medical conditions, and other adults, older adults who are 65 years of age or older.
The Centers for Disease Control estimates that there are 21 million health care workers, 87 million primary workers, 100 million adults with high-risk medical conditions, and another 53 million who are 65 years of age or older.
The US federal government indicated that only 40 million doses of the vaccine against the Coronavirus may be available by the end of December
